Science at Sanofi
Explore latest events, medical insights and trends.
Cutting Edge Science
Discover medical insights and trends from trusted sources and key opinion leaders.
Atopic Dermatitis: How Far Does Treatment Reach?
Can treating the skin change what comes next? This edition opens with a 3,525-patient meta-analysis asking whether new and worsening allergic events can be held back, follows infants and young children through two years of continuous treatment, and closes with what 5,279 patients reveal about anti-drug antibodies and whether they matter.
Atopic Dermatitis: Beyond Symptom Control
What does three years on treatment actually look like? Can relieving itch reshape the nervous system itself? Do topical steroids leave the atopic march unaddressed? And what changes beneath the skin of children under six? Four new studies take these questions on.
Atopic Dermatitis: Real-World Evidence in Focus
Three new papers on atopic dermatitis. What happens when patients in control move to less frequent dosing, how the biologic class compares across trials and real-world use, and what the pooled evidence shows in patients aged 60 and over.
Can Atopic Dermatitis Be Modified, Not Just Managed?
Remission that holds after treatment stops is no longer a hypothetical. This edition opens with a review defining what disease modification in atopic dermatitis would actually require, then looks at what the evidence shows so far: sustained benefit in patients over 60, whether treating children early can change where the atopic march ends, and what happens to skin nerves and barrier proteins after 16 weeks of treatment.
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid (LIBERTY-BP ADEPT)
Improving Airway Function in Type 2 Inflammation _ Insights from global respiratory expert
Atopic Dermatitis: What Changes Beneath the Surface
In this issue, we feature three studies that provide insights into disease modification in atopic dermatitis, examining microbiome restoration, long-term infection outcomes in real-world practice, and clinical responses in erythrodermic presentations.
Events
Stay up to date and register for the latest events and view webinar recordings.
EADV 2026 Highlights: Dupilumab Data Summary
Catch up on EADV 2026 poster highlights: real-world dupilumab data in atopic dermatitis, bullous pemphigoid and prurigo nodularis. For healthcare professionals.
ADVENT 2026 Highlights: From skin to airways
Explores the connections between Type 2 inflammatory diseases and the opportunities to improve patient outcomes through earlier, targeted intervention
ERS 2026 Congress Highlights
Access ERS 2026 Congress highlights on severe asthma, COPD, and biologic therapies. Real-world evidence and clinical insights for HCPs
ATS 2026 Highlights: COPD & Asthma Biologic Insights
Explore ATS 2026 key sessions on dupilumab, COPD biologics, FeNO biomarkers, and asthma remission. Real-world evidence for HCPs
United in RARE: Advancing LSDs Care Across ASIA
The United in Rare: Advancing LSDs Care across Asia event was held on the 22nd to 23rd November 2025 in Bangkok, Thailand. The event aimed to provide a platform for experts across Thailand, Malaysia, Singapore, Taiwan, South Korea and India to share their experiences in management of LSDs by discussing challenges cases and best practices to improve diagnosis and treatment pathways for LSDs.
United in RARE: Advancing LSDs Care Across ASIA
The United in Rare: Advancing LSDs Care across Asia event was held on the 22nd to 23rd November 2025 in Bangkok, Thailand. The event aimed to provide a platform for experts across Thailand, Malaysia, Singapore, Taiwan, South Korea and India to share their experiences in management of LSDs by discussing challenges cases and best practices to improve diagnosis and treatment pathways for LSDs.
EADV 2025 Highlight Webinar Recording Now Available
Access the full recording of the webinar to gain insights on Atopic Dermatitis, Bullous Pemphigoid, and practical applications from leading experts.
Key insights from WSPID 2025 are here!
Discover the latest breakthroughs in pediatric infectious diseases, focusing on Pertussis, Polio and Hib protection.
Video On Demand
Diabetes Clinic Talks EP.4
T2D patients with uncontrolled on Basal insulin switching to iGlarLixi
Diabetes Clinic talks EP.2
Uncontrolled on GLP-1 RA:
What’s the next step?
by Assoc. Prof. Taweesak Wannachalee
Diabetes Clinic talks EP.1
When OADs are not enough: Choosing Gla-300 for stability by Dr. Kampantong Tangweerapong
Diabetes Clinic talks EP.3
T2D patients with post-OADs, high A1C and PPG by Dr. Chonpiti Siriwan
MedTalks With Experts EP.3
LMWH in Acute Coronary Syndromes by DR.PURICH SURUNCHUPAKORN.
[VOD] When GLP-1 RA is not enough: Exploring the Next Step!
Watch now to gain clinical insights from Dr. Wiwat Rodprasert
[VOD] Why Wait? Early treatment after OAD failure
Don’t wait—see how early treatment changes outcomes.
Please log in or register to continue reading.
Login For Healthcare Professionals / เข้าสู่ระบบสำหรับผู้เชี่ยวชาญด้านสุขภาพ
HCP Verification Required
The account is under identity verification process and it will be completed within 48 hours upon your registration. At the end you will receive a confirmation email and you will be able to access the area dedicated to you.
Email Verification Sent
Please check you email for verification emali.
Restricted Content
You do not have the correct verified role to view this content.
Empower-TMS-Video_Final
Empower TMS Video_Final
Request-form